However, like other drugs in its class, tirzepatide shares a similar safety profile, with specific side effects that patients should be aware of
Preclinical work with GLP-1R/GIPR/GcgR triple agonists showed that a balanced triple agonist produced greater body-weight loss than semaglutide, tirzepatide, and dual co-agonists in diet-induced obese mice, reducing weight to near-lean levels at the highest doses
The effects look slightly different for men and women, but the underlying principle is the same: when metabolic health improves, the bodys hormone systems often follow suit
If you are interested in accessing retatrutide through a legitimate route, speak to your GP or a specialist obesity or diabetes clinic about whether any ongoing clinical trials may be appropriate for you
Food and Drug Administration (FDA) issued new label warnings for Ozempic, indicating that it can increase the risk of intestinal blockages
Always consult your prescribing physician before altering your diet, taking new medications, or adding supplements to your GLP-1 regimen
